Our study provides corroborative evidence as it showed
that P. emblica and T. bellerica extracts were selectively toxic
against two cancer cell lines and that, in combination with
doxorubicin and cisplatin, produced an increased growth
inhibitory effect in both A549 and HepG2 cells.